论文部分内容阅读
目的:评价凉血五根汤与孟鲁司特纳联用对幽门螺杆菌感染伴过敏性紫癜患儿的临床疗效。方法:选取2011年1月—2013年1月间来院就诊的幽门螺杆菌感染伴过敏性紫癜患儿152例,按随机数字法将其分为观察组和对照组(各76例);观察组患者予凉血五根汤与孟鲁司特纳联用治疗,对照组患者予孟鲁司特钠治疗,评价2组患儿治疗后皮疹消退时间、腹痛缓解时间及临床治疗的总有效率。结果:观察组患者的皮疹消退时间和腹痛缓解时间均明显少于对照组(P<0.05),前者的临床总有效率为90.79%显著高于对照组为78.94%(P<0.05)。结论:凉血五根汤与孟鲁司特纳联用对幽门螺杆菌感染伴过敏性紫癜患儿的临床疗效较为确切,安全性高。
Objective: To evaluate the clinical effect of Liangxuewuzhitang combined with montelukast on children with Helicobacter pylori infection and Henoch-Schonlein purpura. Methods: 152 children with H.pylori infection and Henoch-Schonlein purpura from January 2011 to January 2013 were randomly divided into observation group and control group (76 cases each). The observation group Patients were treated with Lianglu Wuzhitang and montelukastina, while those in the control group were given montelukast sodium to evaluate the eradication time, the time of abdominal pain relief and the total effective rate of clinical treatment. Results: The eradication time and abdominal pain relief time in the observation group were significantly less than those in the control group (P <0.05). The total effective rate of the former was 90.79%, which was significantly higher than that of the control group (78.94%, P <0.05). Conclusion: Liang Xie Wu Tang and montelukastina combined with Helicobacter pylori infection in children with Henoch-Schonlein purpura clinical efficacy is relatively accurate and safe.